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Survival of Borrelia burgdorferi in ticks and mammals is facilitated, at least in part, by the selective expression of
lipoproteins. Outer surface protein (Osp) A participates in spirochete adherence to the tick gut. As ospB is expressed on
a bicistronic operon with ospA, we have now investigated the role of OspB by generating an OspB-deficient B.
burgdorferi and examining its phenotype throughout the spirochete life cycle. Similar to wild-type isolates, the OspB-
deficient B. burgdorferi were able to readily infect and persist in mice. OspB-deficient B. burgdorferi were capable of
migrating to the feeding ticks but had an impaired ability to adhere to the tick gut and survive within the vector.
Furthermore, the OspB-deficient B. burgdorferi bound poorly to tick gut extracts. The complementation of the OspB-
deficient spirochete in trans, with a wild-type copy of ospB gene, restored its ability to bind tick gut. Taken together,
these data suggest that OspB has an important role within Ixodes scapularis and that B. burgdorferi relies upon
multiple genes to efficiently persist in ticks.
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Introduction
Lyme disease is the most common tick-borne disease in the
United States [1]. The causative organism, Borrelia burgdorferi,
is a microaerophilic spirochete that contains a 910-kb linear
chromosome and at least 21 linear and circular plasmids [2].
B. burgdorferi is composed of several genospecies known
collectively as B. burgdorferi sensu lato (s.l.) of which B.
burgdorferi sensu stricto, Borrelia garinii, and Borrelia afzelii are
responsible for most cases of Lyme borrelliosis worldwide
[3,4]. B. burgdorferi s.l. is maintained in an enzootic cycle that
primarily involves Ixodes ticks and a large range of trans-
mission-competent vertebrate hosts [1, 3–6]. Ticks of the
Ixodes ricinus species complex, including Ixodes scapularis and
Ixodes paciﬁcus in eastern and western North America,
respectively [3], and I. ricinus and Ixodes persulcatus in Europe
and Eurasia [4], respectively, are competent vectors for the
transmission of B. burgdorferi s.l. during engorgement on a
reservoir host [1,3–6]. Studies reported so far tend to show
similar means of transmission and modes of pathogenesis of
the B. burgdorferi s.l. in this group of ticks [3–8]. After entry
into the ticks, B. burgdorferi s.l. replicates and persists within
the gut, then during a subsequent blood meal, migrates
through the vector and is transmitted to a new host [9]. In
humans, B. burgdorferi s.l. initially establishes a localized
infection in the skin at the site of the tick bite known as
erythema migrans, then disseminates via the blood stream and
can chronically infect distant organs, resulting in arthritis,
carditis, and neurological disease [1,10]. Laboratory mice can
be infected with B. burgdorferi s.l. and serve as a reliable model
for the study of Lyme borreliosis [11].
Variation in the synthesis of outer surface proteins (Osps)
is a primary strategy by which B. burgdorferi evades the host
immune system and adapts to various host microenviron-
ments, such as those in a mammal or a tick vector [12–15].
Numerous studies have shown that B. burgdorferi selectively
expresses speciﬁc Osps in distinct phases of its life cycle and
in speciﬁc tissue locations. For example, the expression of B.
burgdorferi OspA and OspB is immediately turned on when the
spirochetes enter and reside within the arthropod vector.
However, during transmission from the arthropod vector to a
vertebrate host, B. burgdorferi downregulate OspA and OspB
expression and upregulate the expression of proteins such as
OspC, DbpA, and BBK32 [16–21]. This selective and temporal
gene expression of OspA and OspB in ticks suggests that
these two proteins may function during early spirochete
colonization and persistence within the tick vector. Indeed, a
recent study showing that OspA mediates spirochete adher-
ence within the tick gut by binding to the I. scapularis
TROSPA protein [22] supports this contention and indicates
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tenance of the natural cycle of the spirochete.
The genes ospA and ospB are highly conserved among B.
burgdorferi isolates in the United States [23,24]. They are
encoded on the linear plasmid (lp) 54 and are generally
expressed by a common promoter [25,26]. Both OspA and
OspB are surface-exposed lipoproteins that are closely
related in terms of sequence and structure [2,27,28]. Since
the discovery of B. burgdorferi as the Lyme disease agent, OspA
has been a subject of intensive investigation [29]. In contrast,
less is known about the role of OspB in the life cycle of B.
burgdorferi. Previous studies have identiﬁed an ospB escape
mutant in a clonal population of infectious B. burgdorferi with
a single base change in the consensus ribosomal binding
sequence and a single nucleotide deletion in the open reading
frame of ospB gene [30]. These changes in the ospB gene
resulted in reduced expression and truncation of this protein
that diminished the penetration capability and infectivity of
the spirochete in the human umbilical vein endothelium cells
[30]. Several reports have indicated that OspB is present on
the surface of B. burgdorferi within unfed ticks [31–33] and that
OspB antibody inhibits B. burgdorferi colonization in I.
scapularis gut [34]. Targeted gene disruption of ospAB operon
inhibited B. burgdorferi colonization and persistence in the tick
gut [35]. While this study highlighted an important role of
OspA in spirochete-tick interaction in vivo, the independent
role of OspB in the life cycle of spirochetes remains unclear.
Progress in the methodologies for genetic manipulation of
virulent B. burgdorferi allows researchers to study the
importance of speciﬁc B. burgdorferi genes that are required
throughout the spirochete life cycle [36]. In the current study,
we have analyzed the functional role of OspB during
spirochete-tick interactions by generating an OspB-deﬁcient
B. burgdorferi, genetically complementing the mutant, and
performing in vivo studies in ticks and mice.
Results
Generation of OspB-Deficient B. burgdorferi
To understand the function of B. burgdorferi OspB, an
isogenic OspB-deﬁcient mutant was generated from infec-
tious B. burgdorferi B31 clone 5A11 by replacing a 554-base pair
(bp) internal fragment of the ospB gene with a Borrelia-adapted
kanamycin resistance cassette, kanAn, through homologous
recombination (Figure 1). The construct used to inactivate the
ospB gene, pXLF11303, is schematically shown in Figure 1A.
After electroporation of clone 5A11 with pXLF11303, three
kanamycin-resistant B. burgdorferi transformants were ob-
tained, of which two were conﬁrmed to be OspB-deﬁcient
by immunoblot (unpublished data). The plasmid content of
these two mutants was analyzed and compared to that of the
wild-type parental clone using an array-based assay [37], which
showed that one of the mutants lost cp9 and the other lost
lp28–1. Because the loss of cp9 has been shown to have little
effect on B. burgdorferi infectivity in mice [38], we chose the
ospB mutant lacking cp9 for further studies.
To verify the desired genomic arrangements in the ospB
mutant, a series of PCRs were performed (Figure 1B). The two
PCRs using primer combinations N21/N27 and N28/N17
veriﬁed the left and the right junctions of the replacement
in the ospB mutant. PCR with primer combination N21/N17
generated different sized DNA fragments from the wild-type
strain and the ospB mutant, which is consistent with the
replacement of the 554-bp internal fragment of the ospB gene
with the 1,248-bp kanAn cassette. Collectively, these PCR
results show that a double-crossover event had occurred in
the mutant, resulting in the inactivation of the ospB gene. RT-
PCR and immunoblot further showed that the ospB mutant
lacked ospB mRNA and was OspB-deﬁcient (Figure 1C and
1D). The ospB mutant had a similar total protein proﬁle as
well as comparable OspA mRNA and protein levels to that of
the wild-type isolate (Figure 1C and 1D).
The OspB-Deficient B. burgdorferi Is Infectious and
Pathogenic in Mice
To evaluate whether the loss of OspB expression affected
the pathogenicity of the spirochete, we examined both the
wild-type and the ospB mutant spirochetes in the murine
model of Lyme borreliosis [39]. Groups of three C3H/HeN
mice were challenged intradermally with in vitro-grown
spirochetes, either the mutant or the wild-type B. burgdorferi,
at a dose of 10
5 spirochetes/mouse (see Materials and Methods
for details). At 25 d post-inoculation, mice were sacriﬁced and
spirochete infection was assessed by serology and in vitro
culturing of the bladder and the spleen. The results of three
independent experiments using a total of 18 mice, nine
infected with wild-type strain and the other nine infected
with the mutant strain, indicated that all mice seroconverted
and were culture-positive for spirochetes (unpublished data).
The ospB mutant spirochetes recovered from murine tissues
remained OspB-deﬁcient, indicating that no reversion had
occurred (Figure 1B, 1C, and 1D). Mice infected with the wild-
type or the ospB mutant B. burgdorferi had similar spirochete
burdens in various tissues, including the bladder, heart,
joints, and skin (p . 0.05, Figure 2A). Joint swelling and
inﬂammation were similar in both groups of mice (p . 0.05,
Figure 2B). Taken together, these data indicate that at the
dose of 10
5 spirochetes/mouse the ospB mutant is fully
infectious and pathogenic in mice.
The OspB-Deficient B. burgdorferi Enters but Cannot
Colonize or Survive in I. scapularis
To determine whether the lack of OspB expression
inﬂuenced the arthropod phase of the B. burgdorferi life cycle,
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Author Summary
Lyme disease is the most common vector-borne disease in North
America and Europe. The causative agent Borrelia burgdorferi is a
bacterium that is maintained in an enzoonotic cycle between Ixodes
ticks and a large range of mammals. Accidental encounters of
infected Ixodes ticks with humans results in the transmission of B.
burgdorferi and subsequent Lyme disease. Given that global control
efforts have met with limited success, the need for developing novel
interventions to combat this infection has become all the more vital.
A better understanding of how B. burgdorferi interacts with its vector
might lead to new ideas for combating the Lyme disease. B.
burgdorferi upregulates outer surface protein (Osp) A and B during
entry into ticks, and OspA contributes to the colonization of
bacterium within the vector gut. We now demonstrate that OspB
also facilitates the colonization and survival of B. burgdorferi in ticks.
This work provides the basis for future studies as to how this protein
facilitates interaction of B. burgdorferi to the tick gut and thus
ultimately a basis for the development of novel strategies to
interrupt the spirochete life cycle.uninfected nymphs were allowed to engorge on mice infected
with either the wild-type or the OspB-deﬁcient B. burgdorferi.
Infection in mice was conﬁrmed by positive ﬂaB PCR from an
ear punch biopsy. Three independent experiments were
carried out with a total of 18 mice (nine infected with wild-
type and the other nine infected with the mutant strain) and a
total of 900 naı ¨ve nymphs (50 nymphs/mice). Five nymphs
were removed from the murine skin at various time points
during feeding, in order to examine the kinetics of spirochete
migration, and the remaining nymphs were allowed to feed to
repletion. Nymphs were subjected to Q-RT-PCR analyses to
determine the spirochete burden (see Materials and Methods
for details). At 8, 24, and 48 h during feeding, the viable
spirochete burden in the ticks fed on the wild-type or the ospB
mutant B. burgdorferi-infected mice were comparable (p .
0.05, Figure 3A). From 72 h (during feeding) onward, the ospB
Figure 1. Characterization of the ospB Mutant and the OspB Complemented Mutant
(A) Strategy for the inactivation of the ospB gene and for the generation of the OspB complemented mutant is shown. The top diagram represents the
suicide vector pXLF11303 used for transformation into B. burgdorferi B31. Due to homologous recombination (double crossover) between the
sequences of pXLF11303 and the native ospAB locus in B. burgdorferi B31, the DospB::kan fragment is inserted into the genome, resulting in the
generation of the ospB mutant (ospB
 ). For the generation of the OspB complemented mutant, the PospAB and ospB gene were PCR-amplified from B.
burgdorferi B31 total genomic DNA and cloned into the multiple cloning site (MCS) of the shuttle vector pKFSS1 [40], resulting in the construct pFGN1
(bottom diagram). The relevant structures of the plasmid and genome are shown. Arrows represent positions of the oligonucleotides used for the PCR
analysis. Primer names are retained as shown in Table 1. Vertical lines represent the restriction enzyme sites. E, EcoRI; N, NotI; and P, PstI.
(B) PCR analyses of genomic DNA isolated from spirochetes were performed to confirm the inactivated ospB locus. wt, the wild-type isolate; ospB, the
ospB mutant; ospB
  , recovered-spirochetes recovered from mice infected with the ospB mutant; ospB
 /pFGN1, the OspB complemented mutant; M, 1-
kb DNA ladder; C in (B and E) refers to PCR reactions without template DNA.
(C) RT-PCR analysis of ospA, ospB, and flaB transcripts in spirochetes grown in BSK-H media. Shown is a gel image of RT-PCR reactions performed with
(þRT) and without ( RT) reverse transcriptase. C refers to RT-PCR reactions without cDNA.
(D) SDS-PAGE (top) and immunoblot (bottom) analysis of whole-cell lysates of spirochetes. Arrows indicate the expression of OspA, OspB, and FlaB.
Immunoblotting analysis performed with monoclonal antibodies directed against OspB (mAb B22J), OspA (C3.78), and FlaB (H9729) were reported
previously [22,50].
(E) PCR analyses of genomic DNA to confirm the OspB complementation.
(F) Restriction digestion of pFGN1 plasmid recovered from the OspB complemented mutant (pFGN1-recovered) and plasmid controls pFGN1 and
pKFSS1. Whole-cell lysate from the OspB complemented mutant was transformed into E. coli DH5a-competent cells and transformed clones were
selected in the presence of spectinomycin (50 lg/ml). Plasmids isolated from E. coli cells were digested with NotI or EcoRI and PstI. Expected sizes of
restrictive fragments are (i) 5,638 bp and 1,906 bp for NotI digestion of pFGN1; (ii) 5,638 bp and 453 bp for NotI digestion of pKFSS1; (iii) 3,840 bp, 2,413
bp, and 1,291 bp for EcoRI-PstI digestion of pFGN1; and (iv) 3,635 bp, 2,413 bp, and 43 bp for EcoRI-PstI digestion of pKFSS1.
doi:10.1371/journal.ppat.0030033.g001
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compared with controls (p , 0.03, Figure 3A). RT-PCR for
ﬂaB and ospA transcripts yielded similar results (Figure 3B).
The observed reduction of spirochetes in ticks fed on mice
infected with the OspB-deﬁcient B. burgdorferi was further
evaluated by immunoﬂuorescence analysis (IFA) of a subset of
the nymphs that were collected at various time points. Tick
gut luminal contents (including the blood meal) as well as gut
tissues washed free of luminal contents were prepared and
subjected to IFA (see Materials and Methods for details). At 72
h of tick feeding, a striking number of wild-type spirochetes
were detected in both blood meal (;13 spirochetes/micro-
scopic ﬁeld) and gut (;8 spirochetes/microscopic ﬁeld) tissue
samples (Figure 3C and 3D). In contrast, the spirochete
number was drastically reduced (;4-fold in blood meal and
;16-fold in gut tissue) in nymphs fed on the ospB mutant-
infected mice (See 72-h panel in Figure 3C and 3D). Of note,
the number of OspB-deﬁcient spirochetes adhering to the
tick gut was signiﬁcantly less (;7-fold, p , 0.0001) in
comparison to the number of the OspB-deﬁcient spirochetes
in the blood meal sample (Figure 3D). IFA of ticks from the
48-h post-feeding phase further corroborated these ﬁndings
(Figure 3C and 3D).
Furthermore, a subset of fully engorged nymphs was
allowed to molt to the adult stage to determine whether the
diminished capacity of ospB mutant to colonize the tick gut
was also reﬂected in the adult stage. The wild-type spirochetes
were readily detected in both luminal content and gut sample
(Figure 3C and 3D). In contrast, ospB mutant spirochetes were
not detected in the gut sample and out of 15 microscopic
ﬁeld observations only one ospB mutant spirochete was seen
in the luminal content sample (p , 0.0001, Figure 3C and 3D).
A quantitative RT-PCR analysis also corroborated the results
(p , 0.02, Figure 3A). Thus, these observations collectively
show that the ospB mutant spirochetes and the wild-type B.
burgdorferi are acquired by ticks at the same rate (note results
at nymphal stage 8, 24, and 48 h during feeding), but the ospB
mutant spirochetes are not able to persist within the luminal
content or fully adhere to the tick gut.
Complementation of the ospB Mutant
To further address whether the loss of OspB expression
results in a defect of B. burgdorferi colonization and survival
i nt h et i c k s ,w ec o n s t r u c t e das t r a i no ft h em u t a n t
complemented in trans with a wild-type copy of the ospB
gene. The promoter of the ospAB operon was fused to the
ospB gene and cloned into the shuttle vector pKFSS1 [40],
resulting in the construct designated as pFGN1 (Figure 1A).
Electroporation of the ospB mutant with pFGN1 resulted in
three positive clones that grew in the BSK-H media
supplemented with streptomycin and kanamycin, of which
one clone had lost both lp25 and lp28–1 plasmids and the
other two clones showed identical endogenous plasmid
proﬁles as its parental isolate (unpublished data). Further-
more, to determine whether these two clones harbored
pFGN1 and were indeed from the ospB mutant, total DNA of
these complemented clones was examined by PCR ampliﬁ-
cation. The three PCRs using primer combinations N21/N27,
N28/N17, and N21/N17 conﬁrmed the inactivated ospB locus
(representative result shown in Figure 1B). PCR with primer
combination N23/N86 generated different sized DNA frag-
ments from the wild-type and the complemented strains,
which conﬁrmed the presence of PospAB-ospB gene fusion,
and PCR ampliﬁcation of the internal sequences of the aadA
gene with primer combinations N83/N84 further conﬁrmed
the presence of pFGN1 in the transcomplemented strains
(representative result shown in 1E). Collectively, these PCR
results revealed the expected amplicons with both comple-
mented clones in all the PCR reactions in comparison to the
wild-type and the ospB mutant. We chose one of these two
clones, designated as the OspB complemented strain (ospB
 /
pFGN1) for further analysis. OspB expression was detected
at both the mRNA and the protein levels in the OspB
complemented strain (Figure 1C and 1D). Furthermore, to
conﬁrm that the OspB complemented strain contained the
pFGN1 plasmid, whole-cell lysates of kanamycin- and
streptomycin-resistant cells were used to transform Escher-
Figure 2. Influence of OspB Deficiency on B. burgdorferi Infectivity for
Mice
Spirochete burden (A) and joint swelling and inflammation (B) in C3H/
HeN mice were quantified at 25 d after mice were needle-inoculated
each with 10
5 wild-type (black bars) or ospB mutant (white bars)
spirochetes. Spirochete burden in mice tissues (bladder, heart, joint, and
skin) was quantified by Q-PCR and shown as pg of flaB DNA per lgo f
mouse b-actin. Both tibiotarsal and knee joints of each mouse were
scored on a scale of 0–3 for joint swelling, exudation of fibrin and
leukocytes into joint spaces, synovial thickening due to proliferation, and
hypertrophy of synovial cells: absent (0), mild (1), moderate (2), or severe
(3). Statistical analysis from Student t test is also shown. Error bars define
standard deviation (þ) from the average value (mean).
doi:10.1371/journal.ppat.0030033.g002
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(A) Results from the experiments with the ticks inoculated by feeding on infected mice are shown. The spirochete burden in nymphal and subsequently
molted adult ticks is quantified by Q-RT-PCR. Value on Y-axis corresponds to pg of flaB/lg of tick b-actin in each cDNA sample. * indicates significant
reduction (p , 0.05, Student t test) of the ospB mutant in ticks in comparison to the wild-type.
(B) RT-PCR analysis of the RNA samples extracted from nymphs is shown. RT-PCR of flaB and ospA transcripts were used to determine the presence of
spirochetes; tick b-actin was used as an internal control for RT-PCR.
(C) Shown is the quantitative assessment of the number of spirochetes from 15 random microscopic field observations. Value on Y-axis corresponds to
the number of spirochetes/microscopic field. Black and white bars in (A and C) indicate values for the wild-type and the ospB mutant spirochetes,
respectively. Error bars define standard deviation (þ) from the average value (mean).
(D) Shown are the representative confocal images of the I. scapularis nymphal ticks (fed on mice infected with the wild-type or the ospB mutant B.
burgdorferi at the indicated time points) and molted adult ticks. Tick blood meal (in nymphs) and luminal content (in adult ticks) and gut tissues were
stained for B. burgdorferi with FITC-labeled anti-Borrelia antibody (green) and for tick cell nucleic acid with propidium iodide (red). Arrow shown in the
luminal content sample of the molted adult tick indicates the only ospB mutant spirochete seen in 15 random microscopic fields. Scale 20 lm.
doi:10.1371/journal.ppat.0030033.g003
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from these E. coli transformants, and restrictive digestions
were performed to verify the recovery of pFGN1 (Figure 1F).
Immunoblot with mAb B22J was also performed to conﬁrm
the presence of OspB protein in these transformed E. coli
cells (unpublished data).
Experimentally infected nymphs were prepared by micro-
injection of cultured spirochetes into the rectal aperture of
uninfected nymphs as previously described [35]. Three
independent experiments were carried out with a total of
nine C3H/HeN naı ¨ve mice (three mice for feeding nymphs
microinjected with wild-type, three for ospB mutant, and
three for OspB complemented strain) and a total of 135
nymphs (15 nymphs/mice). Eight nymphs were forcibly
removed during feeding (48 h) and analyzed by IFA and Q-
RT-PCR. The results of the confocal microscopy revealed
that, in contrast to the ospB mutant, the OspB complemented
strain readily colonized the tick gut tissue (p , 0.0001), albeit
to a lower level than the wild-type isolate (Figure 4A and 4B).
No signiﬁcant difference was seen in the blood meal samples
of the nymphs infected with the wild-type, the ospB mutant, or
the OspB complemented strain (Figure 4A and 4B). Quanti-
tative RT-PCR analysis of cDNA samples also supported the
microscopic observations that showed a signiﬁcant higher
level in the persistence of the OspB complemented strain in
comparison to the ospB mutant (p , 0.001, Figure 4C).
The OspB-Deficient B. burgdorferi Show Reduced Binding
In Vitro to I. scapularis Gut
To further support the role of OspB in the attachment of B.
burgdorferi to tick gut tissue, we performed an in vitro binding
assay to the tick gut extract (TGE) prepared separately from
ﬂat-nymphal ticks and fed-nymphal ticks with the wild-type,
the ospB mutant, and the OspB complemented strains (See
Figure 4. OspB Complementation Restores B. burgdorferi Ability to Survive and Colonize Ticks
Results from the experiments with the ticks inoculated by microinjection via rectal aperture are shown. Approximately 10
3 spirochetes were
microinjected into each tick.
(A) Shown are representative confocal microscopic images of the blood meal and gut samples of microinjected nymphs at 48 h during feeding. Samples
were stained with FITC-labeled anti-Borrelia antibody (green), and tick cell nucleic acid was stained with propidium iodide (red). Scale 20 lM.
(B) Average value of number of spirochetes from 15 random microscopic field observations is shown.
(C) Q-RT-PCR for the total RNA extracted from microinjected nymphs collected at 48 h during feeding is shown. Values on Y-axis represent pg flaB/lg
tick b-actin cDNA.
(D) Shown are the readings from an in vitro binding assay of the wild-type, the ospB mutant, and the OspB complemented mutant B. burgdorferi to TGE-
and FBS-coated wells (see Materials and Methods for details). Values on Y-axis are sample absorbance measured at 450 nm of wavelength. The values
shown are the averages of four independent experiments. Black, open, and gray bars in (B, C, and D) indicate values for the wild-type, the ospB mutant,
and the OspB complemented mutant spirochetes, respectively. Error bars define standard deviation (þ) from the average value (mean). * indicates
values that are statistically significant (p , 0.05, Student t test) in comparison to the ospB mutant.
doi:10.1371/journal.ppat.0030033.g004
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the binding of the ospB mutant to TGE from ﬂat nymphs and
fed nymphs is signiﬁcantly reduced by ;40% and 60%,
respectively, in comparison to the wild-type B. burgdorferi (p ,
0.0001, Figure 4D). In contrast, the OspB complemented
strain showed a signiﬁcant increase in the binding to both
TGE in comparison to the ospB mutant (p , 0.0001) and was
comparable to the wild-type spirochetes (Figure 4D). Taken
together, these data from Figure 4 show that genetic
complementation of the ospB mutant with a wild-type copy
of the ospB gene restores the defects seen in the colonization
and survival of the ospB mutant inside the ticks and can
restore B. burgdorferi binding to the TGE.
Discussion
B. burgdorferi present an amazing variety of Osps that enable
them to invade, colonize, and persist in environmental niches
such as those inside vertebrates or ticks [23,26,41]. OspA,
OspB, OspC, and DbpA are several of the major lipoproteins
of B. burgdorferi that are differentially expressed in response to
the varying environmental conditions [23,26,41]. B. burgdorferi
upregulates OspA and OspB upon entry into ticks, and OspA
contributes to the colonization of spirochetes within the
vector gut [22]. Since ospA and ospB are cotranscribed [25,26]
and colocalized on the bacterial surface [42], we speculated
that OspB might also function for B. burgdorferi within ticks.
To determine the precise role of OspB in the life cycle of B.
burgdorferi, we have generated an OspB-deﬁcient isogenic
isolate of B. burgdorferi. Our data show that OspB facilitates
the colonization and survival of B. burgdorferi within ticks.
While signiﬁcant research has focused on the biological
role of OspA in spirochete life cycle, relatively little
information is available on the role of OspB in the life cycle
of B. burgdorferi. Our in vivo studies with the OspB-deﬁcient B.
burgdorferi show that OspB is essential for the colonization
and persistence of B. burgdorferi in ticks. During tick feeding,
the ospB mutant and the wild-type B. burgdorferi enter the ticks
from infected mice at the same rate. However, after feeding,
the ospB mutant spirochetes are unable to persist within the
blood meal or fully adhere to the tick gut, which also leads to
a signiﬁcant reduction in the number of spirochetes in the
molted adult ticks (Figure 3). The binding of residual OspB-
deﬁcient spirochetes to the tick gut could be attributed to
OspA, as the level of the OspA is unaltered in the OspB-
deﬁcient spirochetes (Figure 1). The luminal face of the gut
epithelium is covered by a dense array of glycoproteins that
may act as ‘‘receptor-buffet’’ for many pathogens [43]. Some
of these glycoproteins are involved in general tissue structure
and digestion [43,44] and some are involved in innate
immunity [45,46]. Our surprising ﬁnding that the reduced
ability of the ospB mutant to attach to the gut epithelium and
its subsequent clearance in the gut may suggest that
adherence to tick gut cells also is critical for some as yet
unknown aspect(s) of spirochete viability.
Our in vivo analysis showed that in contrast to the ospB
mutant, the OspB complemented strain readily colonized tick
gut tissue and showed a drastic increase in its persistence
within ticks, which was comparable to the wild-type isolate
(Figure 4). Furthermore, our in vitro binding assays with the
TGE also supported the in vivo analysis, indicating that in
contrast to the ospB mutant, the transcomplemented strain
binds with a greater afﬁnity to the TGE. In addition, the
difference between the wild-type and the ospB mutant
spirochetes in binding to the fed TGE is signiﬁcantly higher
in comparison to the unfed TGE, suggesting that the levels of
expression of putative OspB gut receptor proteins/glycolipids
might increase during feeding. Furthermore, our in vitro
binding data correlated with a previous study [34] showing
that the B. burgdorferi N40 OspB protein binds signiﬁcantly to
the TGE. Overall, our studies solidify a great body of
experimentation implicating an important role of OspB in
the attachment of B. burgdorferi to the tick gut.
Yang and co-workers recently examined the role of the
ospAB locus in the infectious life cycle of B. burgdorferi [35].
This was accomplished by the generation of an ospAB double
mutant from B. burgdorferi strain BbAH130 (infectious clone
recovered after plating B. burgdorferi strain 297), and it was
found that disruption of both the ospA and ospB genes had no
observable effect on the ability of spirochetes to establish
infection in mice, whereas the locus is critically essential for
colonization of the tick gut [35]. Spirochetes deﬁcient for
both OspA and OspB entered ticks but were unable to persist
within ticks for a long time [35]. Furthermore, complementa-
tion of the ospAB double mutant with both OspA and OspB
expression restores the ability of B. burgdorferi to colonize the
gut [35]. On the other hand, complementation with the ospA
gene alone could only partially restore (50%–60% in
comparison to the wild-type) the colonization defect of the
ospAB mutant [35], suggesting that OspB expression is also
required for the complete restoration of the defect. A
comparison of our data with the prior study [35] indicated
that in contrast to the ospAB double mutant complemented
with the ospA gene alone, the ospB mutant analyzed in our
study was signiﬁcantly impaired in its persistence in the tick
gut. These variations could have been the results of (i) the
different B. burgdorferi strains used in the studies (B31 5A11
versus 297 BbAH130) and (ii) the relative OspA expression in
the ospAB double mutant complemented with the ospA gene
(on a circular plasmid) compared to the ospB mutant analyzed
in our study. Overall, our studies in conjunction with the
previous studies [35] show that (i) absence of OspB alone
could result in severe impairment in colonization and
persistence, and (ii) absence of both OspA and OspB could
lead to the complete impairment in colonization and
persistence of B. burgdorferi in ticks. In an evolutionary
perspective, the conservation of ospB in the genome of B.
burgdorferi is the result of positive selection pressure [23,24],
and thus OspB must be of intrinsic value to the organism.
Our studies suggest that the function of OspB and OspA are
codependent.
OspA and OspB share approximately 50% identity and
62% similarity in their amino acid sequences [2]. The crystal
structures of OspA and the C-terminal region of OspB have
been determined [27,28]. Comparison of the crystal structure
of OspA and C-terminal region of OspB shows that these two
molecules are quite similar [27,28]. The C-terminal region of
OspB adopts the same fold as is observed for the C-terminal
half of OspA [28]. Li and co-workers have identiﬁed that the
C-terminal barrel domain in OspA is a trio of partially buried
charged residues: Arg 139 from beta-strand 10, Glu-160 from
beta-strand 12, and Lys-189 from beta-strand 15 [27]. The
barrel domain of the OspA/B fold features a prominent
cavity, in which the ﬁrst two residues are strictly conserved in
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OspA and Arg in OspB [27,28]. Studies from Li et al. (1997)
and Becker et al. (2005) have proposed that the cavity in the
OspA/B barrel domain might be a ligand binding site for a
small peptide, linear saccharide, or an exposed protein loop
[27,28]. Furthermore, the mapping of amino acid sequences
required for OspA binding to the tick gut showed that the
residues 85–103 and 229–247 are important [47]. The percent
similarity (identity) for the two amino acid stretches are 63
(68) and 84 (79) in OspB amino acid sequence at positions
110–128 and 252–270, respectively [34,47]. Given the struc-
tural and amino acid sequence conservation of OspA and
OspB, it is possible that both lipoproteins recognize either
the same target or closely related targets. It has recently been
shown that OspB antibodies prevent B. burgdorferi coloniza-
tion of I. scapularis gut [34]. Because of the high structural
similarities between OspA and OspB, it could be reasoned
that the OspB antibodies may bind to several epitopes of
OspB on the B. burgdorferi surface, and steric hindrance might
then interfere with OspB binding to the tick gut; or it is
possible that steric hindrance by OspB antibodies also
affected OspA-mediated binding of spirochetes to the tick
gut [34]. Thus, our studies in conjunction with the previous
reported study [34] raises interesting questions regarding the
potential of antibody binding interfering with spirochete
adherence in ticks. In the in vitro-grown B. burgdorferi
cultures, the expression of OspB is lower than OspA (Figure
1D). Since OspA is also involved in the attachment of
spirochetes to the tick gut and since we have found that
OspB-deﬁcient spirochetes are unable to attach to the tick
gut, it is possible that disruption of the OspB resulted in the
interference of the OspA-mediated attachment to TROSPA.
Three scenarios may be envisioned that may elucidate the
possible involvement of OspB in the OspA-TROSPA inter-
actions. Firstly, OspB may directly associate with either OspA
or TROSPA and may form a complex structure that is
required for the tight attachment of B. burgdorferi to the tick
gut. Secondly, OspB may bind to its own receptor within the
gut and this interaction might be required for TROSPA to
interact with OspA. Finally, OspA and OspB might bind to
separate TROSPA molecules on the gut epithelium and both
these interactions might be required for the tight attachment
of B. burgdorferi to the tick gut. With any of these three models,
our ﬁnding that OspB-deﬁcient spirochetes were unable to
colonize or persist in tick gut is signiﬁcant because it suggests
a possible synergistic interaction between OspA, OspB, and
TROSPA.
In summary, these data suggest that OspB plays a critical
role for B. burgdorferi adherence and persistence in ticks.
These studies are not only important in understanding
signiﬁcant roles of spirochete ligands (such as OspB) in
spirochete colonization and survival at arthropod-pathogen
interface, but they also enhance our knowledge in the
development of new therapeutic strategies, such as new
transmission blocking vaccines that may be useful to combat
B. burgdorferi infection.
Materials and Methods
Bacterial isolates and ticks. B. burgdorferi isolate B31 infectious
clone 5A11 that lacks lp5 and contains all other 20 plasmids [38,48]
was used throughout, and will be referred to herein as the wild-type B.
burgdorferi. This B. burgdorferi isolate, its ospB deletion mutant, and the
OspB complemented mutant (ospB
 /pFGN1) were cultivated in vitro
at 33 8C in Barbour-Stoenner-Kelly complete media (BSK-H, Sigma,
http://www.sigmaaldrich.com). Where necessary, antibiotics kanamy-
cin and streptomycin were added to a ﬁnal concentration of 350 lg/
ml and 50 lg/ml, respectively. Spirochetes from in vitro cultures were
needle-inoculated (intradermally) at a dose of 10
5 spirochetes/mouse
and were recovered from cultures of ear punch biopsies at 2 wk after
inoculation. E. coli strain DH5a (Invitrogen, http://www.invitrogen.
com) was used as a cloning host. Unfed I. scapularis nymphs were
obtained from a colony of I. scapularis ticks maintained by Dr.
Durland Fish and Dr. Fred S. Kantor at Yale University.
Construction of mutagenic plasmid and OspB-deﬁcient B. burgdor-
feri. The Borrelia-adapted kanamycin resistance cassette, kanAn,
driven by the ﬂaB promoter, was excised from pTAkanAn [49] by
EcoRI digestion and cloned into the EcoRI site of pBluescript
(Stratagene, http://www.stratagene.com). The resulting construct,
designated pXLF10601, contains two multi-cloning sites ﬂanking
the kanAn cassette, which allows efﬁcient cloning of the 59 and the 39
arms required for homologous recombination. PCR primers N33/N34
and N35/N36 (Table 1) for the construction of mutant spirochetes
were designed to amplify the 59 arm (bp 8883–10257 of lp54) and the
39 arm (bp 10812–12015 of lp54), respectively. The oligonucleotides
were designed based on the sequenced genome of B. burgdorferi B31
isolate M1 [2]. The restriction sites designed in the primers allow
directional cloning of the 59 arm into the SacI-BamHI site and the 39
arm into the NheI-KpnI site of pXLF10601 to generate the construct
pXLF11303 (Figure 1A).
To generate an ospB mutant, 20 lg of pXLF11303 was electro-
porated into B. burgdorferi B31 strain and the mixture was incubated
at 33 8C overnight in 20 ml of BSK-H medium. After an 18–24 h
recovery period, 20 ml of BSK-H medium containing 700 lg/ml
kanamycin was added (ﬁnal concentration of kanamycin, 350 lg/ml)
and 200 ll aliquots were dispensed into two 96-well plates. After 2–3
wk of incubation at 33 8Ci naC O 2 incubator, the wells that contained
kanamycin-resistant (Kan
R) clones were identiﬁed by the color
change of the culture medium. The presence of viable spirochetes
in these wells was subsequently veriﬁed by dark-ﬁeld microscopy. The
homologous recombination between the sequences of pXLF11303
and of the native ospAB operon results in the excision of the ospB gene
with the integration of the DospB::Kan fragment (Figure 1A). The ospB
mutant was conﬁrmed by PCR with primers N21/N27, N28/N17, and
N21/N17 (Table 1 and Figure 1B); RT-PCR (with N16/N11 primers);
and Western blot analysis with monoclonal antibody B22J [50] (Figure
1C and 1D). The plasmid proﬁle of the ospB mutants was examined by
PCR and array hybridization as previously described [37,38].
Complementation of the ospB mutant. DNA fragments carrying the
wild-type copy of promoter sequences of ospAB operon (PospAB) and
the ospB gene were PCR-ampliﬁed from the B. burgdorferi genomic
DNA using primers N29/N30 and N31/N32, respectively (Table 1). The
PCR products were subsequently cloned into the vector pKFSS1 [40]
at the XbaI-PstI site, resulting in pFGN1 (Figure 1A). 20 lg of pFGN1
DNA was electroporated into competent cells of the ospB mutant and
the mixture was incubated at 33 8C overnight in 20 ml of BSK-H
medium. After an 18–24 h recovery period, 20 ml of BSK-H medium
containing 100 lg/ml streptomycin and 700 lg/ml kanamycin was
added (ﬁnal concentration of streptomycin and kanamycin was 50 lg/
ml and 350 lg/ml, respectively) and 200 ll-aliquots were distributed
into two 96-well plates. After 2–3 wk of incubation, streptomycin- and
kanamycin-resistant clones were selected and analyzed by PCR with
primers N23/86 and N83/N84 to detect the PospAB-ospB and the aadA
fragments, respectively. RT-PCR with N16/N11 primers and immuno-
blot with mAb B22J were also performed to conﬁrm the presence of
ospB transcripts and OspB protein, respectively (Figure 1C and 1D).
Plasmid content of the complemented clones was analyzed by PCR as
previously described [38,51].
B. burgdorferi infection of mice via needle inoculation. 10
5
spirochetes from an in vitro-grown culture were needle-inoculated
into the groups of three 3-wk-old C3H/HeN mice. 2 wk later, ear
punch biopsies were taken and DNA was extracted for PCR with
primers N18 and N19 (ﬂaB gene primers, Table 1) to conﬁrm the
infectivity. After 3 wk of infection, tibiotarsal and knee joints were
evaluated for swelling [39]. Mice were sacriﬁced after the tick feeding
and evaluation of joint swelling, and tissues such as skin, heart,
bladder, and joints were harvested for DNA extraction. In parallel,
for recovery of B. burgdorferi from mice, a part of bladder and spleen
was inoculated into BSK-H medium and cultivated at 33 8C.
B. burgdorferi transmission from infected mice to naı ¨ve nymphs.
After a 3-wk inoculation of B. burgdorferi into mice, nymphal I.
scapularis ticks (50 ticks/mice) were allowed to feed on B. burgdorferi-
infected mice. Partially fed nymphs (ﬁve nymphs/time point) were
PLoS Pathogens | www.plospathogens.org March 2007 | Volume 3 | Issue 3 | e33 0008
Role of OspB in Spirochete Life Cycleremoved from the skin of mice at various time points during feeding
(8 h, 24 h, 48 h, and 72 h). Remaining nymphs were allowed to feed to
repletion and were collected at 24 h, 48 h, and 72 h following up to 7
d post-feeding (corresponding to 96 h, 120 h, 144 h, and 10 d,
respectively, from the feeding start time point). Three to ﬁve guts
from each group of nymphs were microscopically dissected in 20 ll
phosphate-buffered saline (PBS) and washed to remove luminal
contents and unbound bacteria. In addition, luminal contents
(including the blood) from the gut were separately isolated from
the fed ticks and subjected to immunoﬂuorescence confocal micro-
scopy as described [35,52]. The spirochete burden in ticks was further
analyzed by quantitative RT-PCR.
Molting of infected nymphs into adults. Nymphal ticks were
allowed to feed to repletion on B. burgdorferi-infected mice. Engorged
nymphs were then collected and transferred into 10-ml glass vials
with vented lid and stored at 22 8C incubator with a relative humidity
of 97% and 16 h:8 h light:dark photoperiod. Engorged nymphs were
allowed to molt to the adult stage for 6–8 wk. Five to seven guts from
adults were microscopically dissected, and guts and luminal contents
were subjected to immunoﬂuorescence confocal microscopy as
described [35,52]. Spirochete burden in adult ticks was further
evaluated by quantitative RT-PCR analysis.
Confocal microscopy and immunoﬂuorescence. The washed gut
and luminal contents were subjected to immunoﬂuorescence
confocal microscopy as described [35,52]. Brieﬂy, gut and luminal
content samples were blocked with PBS containing 0.05% Tween 20
and 5% goat serum for 1 h at 37 8C and then incubated for 1 h at 37
8C with FITC-labeled anti-Borrelia antibody (KPL, http://www.kpl.
com). Samples were subsequently stained with propidium iodide (20
lg/ml) for 3 min at 37 8C followed by mounting with SlowFade-
Antifade kit (Invitrogen). The tissues were viewed using a Zeiss LSM
510 scanning laser confocal microscope equipped with an argon/
krypton laser (Zeiss, http://www.zeiss.com).
Microinjection of B. burgdorferi into ticks. Microinjection of B.
burgdorferi into the ticks was performed as described [35]. Brieﬂy, B.
burgdorferi isolates (wild-type, ospB mutant, and OspB complemented
mutant) were cultivated under normal conditions in BSK-H medium
with or without antibiotics. Log-phase cultures were centrifuged and
concentrated in a fresh BSK-H media to a density of 10
9 spirochetes
per ml. 1 ll of the re-suspended cultures was then loaded into a 1-mm
diameter glass capillary needle (World Precision Instruments, http://
www.wpiinc.com) and approximately 1 nl (10
3 spirochetes) was
injected into each tick via the rectal aperture using femtojet
microinjector system (Eppendorf AG, http://www.eppendorf.com) as
described [22,35]. 15 microinjected ticks were reared in a humid
chamber for 12 h and fed on naı ¨ve mice. Five to seven partially fed
ticks were detached during feeding at 48 h. The spirochete burden in
ticks was further analyzed by confocal microscopy and quantitative
RT-PCR.
PCR. For RT-PCR analysis of B. burgdorferi grown in vitro, total
RNA was isolated from B. burgdorferi B31 and its derived mutants
using Nucleospin RNAII kit (BD Biosciences, Clontech, http://www.
clontech.com) and converted to cDNA using iScript cDNA synthesis
kit (Bio-Rad, http://www.bio-rad.com). RT-PCR for the ospB, ospA, and
ﬂaB genes was performed using the primer combinations N16/N11,
N21/N22, and N12/N13, respectively (Table 1). For the RT-PCR
analysis of B. burgdorferi RNA in ticks, RNA from the fed-tick extracts
(three nymphs/group) was extracted and converted to cDNA. The
cDNA was used as a template for the ampliﬁcation of ﬂaB using
primers N18 and N19 and for tick b-actin, using primers N3 and N20.
For the quantiﬁcation of the spirochete burden in mice and ticks,
quantitative PCR (Q-PCR) and quantitative RT-PCR (Q-RT-PCR)
analysis was performed, respectively, as described [22,35]. The 225-bp
ﬂaB amplicons were quantiﬁed using the oligonucleotides N18 and
N19 and iQ-SYBR Green Supermix (Bio-Rad). The reaction con-
ditions are initial 95 8C for 10 min followed by 94 8C for 30 s, 60 8C for
1 min, 72 8C for 1 min for 35 cycles. As an internal control and to
normalize the amount of template, tick actin amplicons were
quantiﬁed using N3/N20 (for tick samples), and mouse b-actin
amplicons were quantiﬁed using the oligonucleotides N25 and N26
(for mice samples). Standard curves for ﬂaB, tick actin, and mouse b-
actin were prepared using 10-fold serial dilutions of known quantities
(4 ng–0.4 fg for pCR2.1-ﬂaB; 5 ng–0.5 fg for tick b-actin; 5 ng–0.5 fg for
mouse b-actin).
Table 1. Oligonucleotides Used in This Study
Name
a Sequence (59–39)
b Description
c
N3 GGTATCGTGCTCGACTC actin-(tick), QPCR
N11 CCGCCTACAAGACTTCCTTCA ospB, RT-PCR
N12 GCTCAAATAAGAGGTTTGTC flaB, RT-PCR
N13 ATTCCAAGCTCTTCAGCTG flaB, RT-PCR
N16 CGACGCGTCGATAAGGAGAATTTATGAGATTATTAATAGGATTTG ospB, RT-PCR
N17 CCGGTCGACGTTATTTTAAAGCGTTTTTAAGCTCTGAAAGAT ospB, PCR
N18 TTCAATCAGGTAACGGCACA flaB, QPCR
N19 GACGCTTGAGACCCTGAAAG flaB, QPCR
N20 GGCGACGTAGCAG actin-(tick), QPCR
N21 CAGTAGATTTGCCTGGTGAAATGA ospA, RT-PCR
N22 CAAGTCTGGTTCCGTCTGCTCT ospA, RT-PCR
N23 CTATTTGTTATTTGTTAATCTTATAATATAATTATACTTGTA PospAB PCR
N25 TCACCCACACTGTGCCCATCTACGA actin-(Mouse), QPCR
N26 GGATGCCACAGGATTCCATACCCA actin-(Mouse), QPCR
N27 CGAGCCCATTTATACCCATATAAATCA KanAn, PCR
N28 GGATTCAGTCGTCACTCATGGTGA KanAn, PCR
N29 GCGACTAGTACGAAGCGCATCTTTCAAGCTA PospAB cloning primer
N30 GCGGGATCCTTCTCGTCAAGGCTGCTAACAT PospAB cloning primer
N31 CGCGGATCCATAAGGAGAATTTATGAGATTA ospB cloning
N32 CGCATGCATTATTTTAAAGCGTTTTTAAGCTCTGAA ospB cloning
N33 AAGAGAGCTCATCCCCACAAGAGTCAACAC ospB knockout
N34 CTATGGATCCTAACGCTAAAGCAAATCCTA ospB knockout
N35 GGAGCTAGCGTAGGCGGAAAAACAACAGT ospB knockout
N36 CGCGGTACCTAGCATTTTTCTTTTTCGTATTTA ospB knockout
N83 CCCCTGGAGAGAGCGAGATTCT aadA, PCR
N84 CCCAGTCGGCAGCGACA aadA, PCR
N86 CAGCATCTGTTATTTGTGAGTATTCAAGT ospB, RT-PCR
aName of the oligonucleotide in the lab collection.
bNucleotide sequence is shown from 59–39. The 59overhangs of the primers (incorporated for cloning purposes) are indicated in italics and restriction sites are underlined.
cRelevant description and purpose of the primer usage is shown.
doi:10.1371/journal.ppat.0030033.t001
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Role of OspB in Spirochete Life CycleSpirochete binding to TGE. Guts from ﬂat-nymphal ticks (40 ticks)
and fed-nymphal ticks (25 ticks) were dissected in PBS and
homogenized on ice using Kontes micro homogenizer (VWR
Scientiﬁc Products, http://www.vwrsp.com). Total protein concentra-
tions in the TGE were determined using the Bio-Rad Protein Assay
Kit (Bio-Rad Laboratories). 100 ll of TGE (5 lg/ml) in PBS was used to
coat the wells of 96-well plates (Nunc, http://www.nuncbrand.com).
Control wells were coated with fetal bovine serum (FBS) (10 lg/ml).
The coated wells were incubated for 4 h at 33 8C with 10
7 spirochetes
per well in PBS-Tween 20 supplemented with 5% FBS. Unbound
spirochetes were washed away with PBS-Tween, followed by
incubation for 1 h at 33 8C with FITC-labeled anti-Borrelia antibody
(KPL). Binding was detected using anti-FITC IgG-horseradish
peroxidase (Amersham, http://www.gehealthcare.com) as a secondary
reagent and TMB microwell peroxidase substrate (KPL) was used for
color development. The reactions were stopped after 15 min
incubation using TMB stop solution (KPL) and optical density (OD)
was read at 450 nm.
Antibodies and protein analysis. For sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) analysis, 10 ml of
actively growing spirochetes (10
7 cells/ml) were centrifuged and re-
suspended in 25 ll Laemmli Sample buffer (Bio-Rad). Samples were
incubated in boiling water for 5 min and loaded onto 12% SDS-PAGE
gels. Gels were stained with Simply Blue SafeStain (Invitrogen) and
processed according to the manufacturer’s instruction. Immunoblot-
ting analysis was performed with the protein extracts from 10
7
spirochetes and processed as described [52]. Monoclonal antibodies
directed against OspB (mAb B22J), OspA (C3.78), and FlaB (H9729)
were reported previously [22,50].
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